SREBF1 and metabolic dysfunction-associated steatohepatitis: The results showed that both SREBP1 and SREBP2, as well as their intronic miRNAs (miR-33b and miR-33a, respectively), were elevated in obese steatosis and obese MASH individuals compared with obese healthy individuals (Supplemental Figure 1 and Figure 1B).